Exabis Library
Welcome to the e-CCO Library!
P747 Adherence to ECCO guidelines for cancer surveillance is associated to the detection of early cancer: A retrospective, single-centre, cohort study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P747: A sharp increase of using biologics for IBD in Israel: a population- based report from the epiIIRN database
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P747: Extracolonic and colonic cancer risk in patients with ulcerative colitis and primary sclerosing cholangitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P747: Predictors of thiopurine treatment failure in ulcerative colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P747: The impact of COVID-19 on patients with Inflammatory Bowel Disease: A population-based study using artificial intelligence.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P748 Characteristics of inflammatory bowel diseases in different stage of adolescence
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P748: Clinical outcomes and prognostic factors of methotrexate therapy in combination with anti-TNF agents in inflammatory bowel disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P748: High stress and significant decrease in productivity in caregivers of IBD patients
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P748: Pharmacokinetics, relative bioavailability, and dose proportionality of a tablet formulation of the sphingosine 1-phosphate-1 receptor modulator VTX002 (formerly OPL-002)
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P748: Retrospective study on incidence rates of NAFLD and advanced liver fibrosis in Crohn's disease and ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P749 Epidemiological and clinical characterisation of inflammatory bowel disease (IBD) in Latin America and the Caribbean: The EPI-LATAM IBD study from the Pan American Crohn’s colitis organisation
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P749: A comparative analysis of low bioavailability steroids in inducing clinical response and remission in ulcerative colitis: Budesonide MMX as the safest option
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P749: Crohn's disease stricture response and resolution with adalimumab therapy demonstrated with intestinal ultrasound. The STRIDENT randomised trial.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P749: Early environmental and lifestyle factors are associated with developing inflammatory bowel disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P749: Impact of psycho-social variables on the activity of inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P750 Prevalence and characteristics of incidentally diagnosed inflammatory bowel disease during screening colonoscopy
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P750: Association between the use of antihypertensive agents and disease severity in patients with inflammatory bowel disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P750: Biosimilar Infliximab Switching is Not Associated with Adverse Outcomes: A Real-World Effectiveness Analyses in a National U.S. Cohort of U.S. Military Veterans with Inflammatory Bowel Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P750: Predictors of quick remission after cyclosporine A therapy in Paediatric ulcerative colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P750: Prevalence and risk factors of cholelithiasis in patients with Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM